AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Pluri Inc.

Regulatory Filings Mar 21, 2011

Preview not available for this file type.

Download Source File

CORRESP 1 filename1.htm zk1109635.htm Licensed to: ZK Global Document Created using EDGARizer 5.3.1.0 Copyright 1995 - 2011 Thomson Reuters. All rights reserved.

Correspondence

PLURISTEM THERAPEUTICS, INC.

MATAM Advanced Technology Park, Building No. 20, Haifa, Israel 31905

March 21, 2011

VIA EDGAR AND FAX

Jim B. Rosenberg

Senior Assistant Chief Accountant

U.S. Securities and Exchange Commission

Division of Corporation Finance

Washington, DC 20549

Re: Pluristem Therapeutics, Inc.

Form 10-K for the Fiscal Year Ended June 30, 2010

Filed September 21, 2010

File No. 001-31392

Dear Mr. Rosenberg:

We have received your letter dated March 10, 2011 and are in the process of preparing responses to your comments. As discussed with Ms. Tabatha Akins, we do not expect to be able to respond within 10 business days of your letter. However, we anticipate that we should be able to respond to your comments by March 31, 2011.

Sincerely,
/s/ Yaky Yanay
Yaky Yanay
Chief Executive Officer

Talk to a Data Expert

Have a question? We'll get back to you promptly.